The 20 Best Endophthalmitis Doctors in California, US

Ehsan Rahimy is an Ophthalmologist in San Carlos, California. Dr. Rahimy has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Endophthalmitis. His top areas of expertise are Retinal Vein Occlusion, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Trabeculectomy. Dr. Rahimy is currently accepting new patients.

We provide exceptional care and compassionate service to optimize the vision of patients with retinal disease. A native of Chicago, Dr. Chang prepared for her future career in retinal surgery by starting piano lessons at the age of 4, and performed a Mozart piano concerto with the University of Houston orchestra at the age of 8. After moving to Seattle, she began her studies at the University of Washington at the age of 14, graduating Phi Beta Kappa and summa cum laude with a major in piano performance. She then headed east to Columbia University’s College of Physicians and Surgeons where she was awarded her medical degree and elected to the Alpha Omega Alpha honor society. While at Columbia, she received a full-tuition scholarship to earn her masters degree in biostatistics at the Mailman School of Public Health. Following internship at the University of Pennsylvania, she became a resident in Ophthalmology at the Wilmer Eye Institute at Johns Hopkins. There she first met her future colleagues, Drs. Tony Tsai and Robert Equi. She continued at Wilmer for her retina fellowship, where she was the inaugural Mary Hutcheson fellow. She garnered many accolades at Johns Hopkins, among them the prestigious Society of Heed and Michels fellowships. Dr. Chang has received numerous prizes and grants for her research, and is the author of many journal articles and book chapters. Her scientific work has been published in the most respected journals in our field, including Ophthalmology, Archives of Ophthalmology, and Retina. When not at the office, Dr. Chang is outnumbered at home by her three young sons, two male miniature dachshunds and her radiologist husband. In addition to tickling the ivories, she enjoys swing dancing, skiing, and baking. Dr. Chang is rated as a Distinguished provider by MediFind in the treatment of Endophthalmitis. Her top areas of expertise are Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Retinal Detachment.

Dr. Small is a board-certified ophthalmologist with years of specialized training and over two decades of experience in retinal disorders, making him a leading expert in his field. Using the very latest methods, Dr. Small can diagnose and treat the full spectrum of retinal disorders, including diabetic retinopathy, macular degeneration, retinal detachments, retinal vascular disease and more. Throughout his career, Dr. Small has been involved in research and clinical trials backed by over $10 million in funding that will improve patient care for years to come. Dr. Small is also the published author of over 300 articles relating to all aspects of retinal disease. For over a decade, Dr. Small was both Professor and Director of the Macular Disease Center and Retinal Research lab at the Jules Stein Eye Institute at UCLA. He has taught nearly 100 ophthalmologists and optometrists. In addition, Dr. Small is a frequent guest lecturer and recognized expert both nationally and internationally.Finally, Dr. Small will treat you with the utmost concern and compassion you deserve every step of the way. Your appointments with him are unhurried and informative, and he will explain everything to you in simple, easy-to-understand language. It's why Dr. Kent Small is trusted by nearly 300 Glendale and Los Angeles area ophthalmologists, optometrists and other medical specialists for their patients who need retinal care.Innovative, experienced and highly personalized retinal care. Dr. Small is rated as a Distinguished provider by MediFind in the treatment of Endophthalmitis. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Endophthalmitis, Retinal Vein Occlusion, and Vitrectomy.

We provide exceptional care and compassionate service to optimize the vision of patients with retinal disease. Dr. Pearlman is rated as a Distinguished provider by MediFind in the treatment of Endophthalmitis. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, and Retinal Detachment.

Roger Goldberg is an Ophthalmologist in Vacaville, California. Dr. Goldberg has been practicing medicine for over 18 years and is rated as a Distinguished provider by MediFind in the treatment of Endophthalmitis. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Central Serous Chorioretinopathy, Vitrectomy, and Cataract Removal. Dr. Goldberg is currently accepting new patients.

Shalini Yalamanchi is an Ophthalmologist in Santa Rosa, California. Dr. Yalamanchi is rated as a Distinguished provider by MediFind in the treatment of Endophthalmitis. Her top areas of expertise are Central Serous Chorioretinopathy, Endophthalmitis, Usher Syndrome Type 2A, and Cone-Rod Dystrophy. Dr. Yalamanchi is currently accepting new patients.

Sarju Patel is an Ophthalmologist in Sacramento, California. Dr. Patel is rated as a Distinguished provider by MediFind in the treatment of Endophthalmitis. His top areas of expertise are Uveitis, Diabetic Retinopathy, Late-Onset Retinal Degeneration, and Age-Related Macular Degeneration (ARMD).

Dr. Jay Stewart is an ophthalmologist who specializes in treating disorders of the retina and vitreous (the thick transparent substance that fills the center of the eye). His expertise includes conditions such as age-related macular degeneration, diabetic retinopathy, ocular trauma, retinal detachment, retinal vascular diseases and uveitis (swelling of the uvea, the middle layer of the eye). In his research, Stewart studies diabetic retinopathy, drug delivery to the eye, and the permeability and biomechanics of eye tissues. Stewart earned his medical degree at Harvard Medical School and completed a residency in ophthalmology at UCSF. He completed a fellowship at the Doheny Eye Institute and won the vitreoretinal surgery award from the Ronald G. Michels Fellowship Foundation, which funds outstanding young scholars. Stewart is a member of the American Academy of Ophthalmology, American Society of Retina Specialists and Retina Society. Dr. Stewart is rated as a Distinguished provider by MediFind in the treatment of Endophthalmitis. His top areas of expertise are Retinal Detachment, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, Vitrectomy, and Trabeculectomy.

Our mission is to preserve and restore vision providing the highest level of patient care using compassion, innovation and the latest technologies in a caring, state of the art facility. Dr. Gallemore is rated as a Distinguished provider by MediFind in the treatment of Endophthalmitis. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Detachment, Retinal Vein Occlusion, and Vitrectomy.

Khaled Tawansy is an Ophthalmologist in Lynwood, California. Dr. Tawansy has been practicing medicine for over 35 years and is rated as a Distinguished provider by MediFind in the treatment of Endophthalmitis. His top areas of expertise are Retinal Detachment, Optic Atrophy Type 1, Optic Nerve Atrophy, and Diabetic Retinopathy.

We provide exceptional care and compassionate service to optimize the vision of patients with retinal disease. Dr. Reed is rated as an Advanced provider by MediFind in the treatment of Endophthalmitis. His top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Vogt-Koyanagi-Harada Disease.

We provide exceptional care and compassionate service to optimize the vision of patients with retinal disease. Dr. Telander is rated as an Advanced provider by MediFind in the treatment of Endophthalmitis. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Leber Congenital Amaurosis, Sorsby Fundus Dystrophy, and Vitrectomy.

We provide exceptional care and compassionate service to optimize the vision of patients with retinal disease. Dr. Equi was raised in California and attended college at UCLA, graduating Summa Cum Laude. He began his work in ophthalmology while at UCLA, researching treatments for retinal diseases at the famous Jules Stein Eye Institute. He subsequently earned his M.D. at the prestigious University of California, San Francisco, School of Medicine. He completed his internship at Scripps-Mercy Hospital in San Diego before heading east to the Wilmer Eye Institute at Johns Hopkins University to pursue his residency training in ophthalmology. Following residency, he returned to California to be a fellow in vitreo-retinal surgery at the Doheny Retina Institute, part of USC?s Keck School of Medicine. Dr. Equi was awarded the inaugural Heed Foundation Clinician-Scientist award in 2002, one of only two ophthalmologists in the country to receive that award. Following his fellowship, he returned to Johns Hopkins to serve as the Assistant Chief of Service of the Wilmer Eye Institute following in the footsteps of his colleagues, Drs. Arun Patel and Joel Pearlman. Dr. Equi has published papers and written chapters on treatments for infectious diseases of the retina, diabetic eye disease, and macular degeneration. He has been involved in several national clinical trials in the treatment of macular degeneration. He is a member of the American Academy of Ophthalmology and is Board Certified. Dr. Equi is an avid long distance runner and cyclist, having competed in marathons and triathlons, and he describes himself as a die-hard family man. Dr. Equi is rated as an Advanced provider by MediFind in the treatment of Endophthalmitis. His top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Retinal Detachment.

,,. Dr. Medina is rated as an Advanced provider by MediFind in the treatment of Endophthalmitis. His top areas of expertise are Diabetic Retinopathy, Retinal Detachment, Age-Related Macular Degeneration (ARMD), and Late-Onset Retinal Degeneration.

Dr. Tsai was born in New York City and raised in rural Wisconsin. Since leaving the north woods, he has crisscrossed the country for his education and training, consistently earning recognition along the way for exceptional achievement. He graduated Summa Cum Laude from Harvard University as a member of Phi Beta Kappa. As a student at the prestigious School of Medicine at Washington University in Saint Louis, Dr. Tsai's education was fully supported by a merit-based George Wilson Distinguished Student Scholarship. He earned his M.D. and graduated Alpha Omega Alpha with a Merck Manual Award – an award given to three graduates for outstanding academic achievement. He completed his internship at the University of California, San Francisco, before being awarded the Bank of America Giannini Foundation Medical Research Fellowship and the Knights Templar Eye Foundation Pediatric Ophthalmology Research Grant to spend two years in the Ocular Oncology Laboratory at UCSF developing improved methods of genetic testing for patients with retinoblastoma. He then headed east for his residency in ophthalmology at the Wilmer Eye Institute at Johns Hopkins, where he first met his future colleagues, Drs. Joel Pearlman, Rob Equi, and Margaret Chang. He then returned to UCSF to complete his clinical fellowship in ocular oncology in 2006-7.Dr. Tsai has served on the academic faculty at the Wilmer Eye Institute and at UCSF. He has published papers and presented work at national meetings on retinoblastoma, uveal melanoma, and intraocular lymphoma. He has also served as a peer-reviewer for several journals, including Ophthalmology and Archives of Ophthalmology. He is a member of the American Academy of Ophthalmology, the American Medical Association, and the American Society of Retina Specialists. He is a past President, Program Chair, and Secretary of the Alta Ophthalmology Society in Sacramento. He is board certified by the American Board of Ophthalmology.Aside from his mission to provide compassionate care for his patients, Dr. Tsai enjoys eating and he tries to compensate for this by indoor rock climbing and chasing after his two young children. On Sundays in the fall, he shows his Wisconsin roots as a die-hard Green Bay Packers fan.We provide exceptional care and compassionate service to optimize the vision of patients with retinal disease. Dr. Tsai is rated as an Advanced provider by MediFind in the treatment of Endophthalmitis. His top areas of expertise are Melanoma of the Eye, Choroid Plexus Carcinoma, Retinal Detachment, and Metastatic Uveal Melanoma.

David Cupp is an Ophthalmologist in Sacramento, California. Dr. Cupp is rated as an Advanced provider by MediFind in the treatment of Endophthalmitis. His top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Retinal Detachment. Dr. Cupp is currently accepting new patients.

caring, good listener, dedicated, intelligent, compassionate, committed, healing and reassuring. Dr. Jumper is rated as an Advanced provider by MediFind in the treatment of Endophthalmitis. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Neuroretinitis, Vitrectomy, and Trabeculectomy.

Dr. Nathan C. Steinle received his undergraduate and medical training in his home state of South Dakota, where he was named the class valedictorian and graduated with summa cum laude honors. After completing his ophthalmology residency in Kentucky, Dr. Steinle had the fortune of performing his surgical vitreoretinal fellowship at the renowned Cleveland Clinic. The Cleveland Clinic is a world-class institution and is consistently ranked as one of the top hospitals in all of healthcare. While at the Cleveland Clinic, Dr. Steinle worked closely with Dr. Daniel F. Martin, who is one of the world’s leading experts in ophthalmic research including the groundbreaking Comparison of Age Related Macular Degeneration Treatment Trials (CATT).Dr. Steinle earned multiple awards for excellence during his surgical training. He was given the honor of being named Chief Resident in addition to earning the prestigious Wirtschafter award recognizing the finest resident teacher. During his fellowship, he was named the best fellow teacher while at the Cleveland Clinic. Dr. Steinle has published numerous book chapters and research articles on topics including age related macular degeneration, diabetic retinopathy, and ocular trauma.Dr. Steinle has been an investigator in a number of clinical research trials including the investigation of novel therapies for neovascular age related macular degeneration, retinal vein occlusion, and diabetic retinopathy. Dr. Steinle is a Board Certified Ophthalmologist, and is a member of the American Academy of Ophthalmology, the Association for Research in Vision and Ophthalmology, the American Society of Retina Specialists, and the American Medical Association.As vitreoretinal specialists, we provide comprehensive medical and surgical treatment for all disorders of the retina, macula and vitreous. We focus on the diagnosis, prevention and treatment of these conditions. Many abnormalities of the retina and vitreous may cause visual loss. These disorders include macular degeneration, diabetic retinopathy, retinal detachment, macular holes, macular edema and epiretinal membranes. Our practice has multiple locations throughout Central California to serve our patients. Dr. Steinle is rated as an Advanced provider by MediFind in the treatment of Endophthalmitis. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Geographic Atrophy, Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.

We provide exceptional care and compassionate service to optimize the vision of patients with retinal disease.  He participates in trials to treat macular degeneration (Miravant and Visudyne), and the use of Vitrase to clear vitreous hemorrhage. Dr. Wendel strives to provide expert retinal care. Dr. Wendel is rated as an Advanced provider by MediFind in the treatment of Endophthalmitis. His top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Retinal Artery Occlusion.

Nasir earned his medical degree from the University of Texas Health Science Center at San Antonio where he ranked first in his class. He was honored as a recipient of the Lange Medical Publications Award. Following his internship at Baylor College of Medicine, he completed his residency at the University of California, San Francisco, a well known center for research and clinical practice.Dr. Nasir pursued post-graduate work as a Fellow in Vitreoretinal Research and Clinical Studies at Duke University, where he also trained with Dr. Robert Machemer, who invented the first vitrectomy machine and is considered the father of modern vitreous surgery. He was chosen as a Heed Ophthalmic Foundation Fellow and was the recipient of a grant for the Research to Prevent Blindness Foundation.Dr. Nasir is a diplomate of the American Board of Ophthalmology, a member of the American Society of Retina Specialists, the American Academy of Ophthamology, and the Association for Research in Vision and Ophthalmology. Dr. Nasir is a co-founder of the California Retina Research Foundation and has been the principal investigator or coinvestigator for numerous national clinical trials at California Retina Consultants. His research interests include choroidal neovascularization associated with age-related macular degeneration, as well as adjunctive pharmacological therapies used in the surgeries for diabetic retinopathy and proliferative vitreoretinopathy. The results of his work have been reported in distinguished journals such as the American Journal of Ophthalmology, Ophthalmology, the British Journal of Ophthalmology and Retina. He and his colleagues at California Retina Consultants published the first series of patients treated with Avastin for age-related macular degeneration and subsequent peer reviewed articles for the use of Avastin for other retinal diseases. Dr. Nasir is a representative and a past vice president of the California Academy of Ophthalmology as well as a member of S.E.E. International and with his colleagues regularly train ophthalmologists from developing countries.Clinically, Dr. Nasir is particularly interested in age-related macular degeneration, diabetic retinopathy, complex retinal detachments and macular surgery. His research and surgical foci are balanced with a keen concern for patient care.As vitreoretinal specialists, we provide comprehensive medical and surgical treatment for all disorders of the retina, macula and vitreous. We focus on the diagnosis, prevention and treatment of these conditions. Many abnormalities of the retina and vitreous may cause visual loss. These disorders include macular degeneration, diabetic retinopathy, retinal detachment, macular holes, macular edema and epiretinal membranes. Our practice has multiple locations throughout Central California to serve our patients. Dr. Nasir is rated as an Advanced provider by MediFind in the treatment of Endophthalmitis. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Vein Occlusion, and Retinal Artery Occlusion.